In this way, our study focused on miR-34a and ANRIL/UFC1 effects following the available experimental studies and uncovered the extraordinary mechanisms associated with these molecules in NSCLC. The gene discussed is CDKN2B-AS1; the disease is non-small cell lung carcinoma.